Levocetirizine better protects than desloratadine in a nasal provocation with allergen. [electronic resource]
Producer: 20040513Description: 669-76 p. digitalISSN:- 0091-6749
- Adult
- Albumins -- metabolism
- Allergens -- immunology
- Biomarkers -- analysis
- Cetirizine -- therapeutic use
- Cross-Over Studies
- Differential Threshold
- Double-Blind Method
- Female
- Histamine H1 Antagonists, Non-Sedating -- therapeutic use
- Humans
- Hypersensitivity -- drug therapy
- Loratadine -- analogs & derivatives
- Male
- Nasal Lavage Fluid -- chemistry
- Nasal Provocation Tests
- Piperazines -- therapeutic use
- Poaceae -- immunology
- Pollen -- immunology
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.